Summary
A 35-year-old program analyst for a defense contractor was granted a security clearance despite concerns under Guideline E (Personal Conduct) and Guideline H (Drug Involvement). The applicant admitted to using marijuana on various occasions from approximately May 2008 to May 2022, including while holding a sensitive position. Additionally, she acknowledged falsifying material facts on an e-QIP completed in October 2017.
However, the Administrative Judge found that mitigating factors outweighed these disqualifying conditions. The applicant demonstrated a commitment to abstinence from illegal drugs since May 2022. She proactively sought help by self-referring to a licensed substance abuse counselor, who provided a favorable evaluation.
Crucially, the applicant was candid about her past drug use in subsequent e-QIP submissions and during personal subject interviews. The Administrative Judge concluded that her past conduct did not undermine her overall trustworthiness and reliability, leading to the decision to grant eligibility for access to classified information.
Why the Applicant Prevailed
- The applicant demonstrated a commitment to abstinence from illegal drugs since May 2022.
- She self-referred to a licensed substance abuse counselor and received a favorable evaluation.
- The applicant was candid about her past drug use in subsequent e-QIPs and personal subject interviews.
Conditions Referenced
- DC ¶ 25(a)raisedAny Substance Misuse
- DC ¶ 25(c)raisedIllegal Possession of a Controlled Substance
- DC ¶ 25(f)raisedIllegal Drug Use While Holding a Sensitive Position
- MC ¶ 26(a)appliedBehavior Happened so Long Ago or Was Infrequent
- MC ¶ 26(b)appliedAcknowledgment of Drug Involvement and Evidence of Actions Taken to Overcome the Problem
Key Rule Quoted
“Eligibility for access to classified information may only be granted "upon a finding that it is clearly consistent with the national interest to do so."”
Procedural Posture
- SOR issuedApr 30, 2025
- Answer filedJun 24, 2025
- Hearing heldDec 10, 2025rescheduled from October 14, 2025
- Decision dateFeb 2, 2026
Cite For
- Mitigation of Drug Involvement Under Guideline H
- Mitigation of Personal Conduct Concerns Under Guideline E
- Importance of Demonstrating Rehabilitation and Commitment to Abstinence